An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

NCT06996652 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

REM Sleep Behavior Disorder

Interventions

DRUG: Adalimumab
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]
[object Object]